OUR TEAM

BIG HEARTS TO MAKE A BIG IMPACT

• Impact tech entrepreneur – SoftBank and Hitachi.
• Founded Maddie BioGenetics due to his daughter‘s rare disease condition and the lack of solace found in the healthcare system.
• Bachelor of Science in Chemical Engineering from Illinois Institute of Technology.
• Contributed to early security and privacy standards, which laid the groundwork for his involvement in HIPAA regulation work.

• 10+ years as a structural biologist
• Research has focused on protein complexes and RNA–protein interactions, particularly in the human SMN complex and archaeal/yeast H/ACA snRNPs.
• Single particle reconstitution, cryoET, AlphaFold2 for structure prediction, and protein analysis expert.
•  Strong background in X–ray crystallography, protein purification, and cell culture.
• PhD in Biotechnology and Post–Doctoral Fellow at the Howard Hughes Medical Institute / University of Pennsylvania.

• Launched Vizient‘s first specialty pharmacy data platform on Microsoft Azure serving 100+ hospital systems and 25+ drug MFGs. 
• Led v1 products/platforms from $0 – $1Bn+ revenue.
• MSEE, BSEE in Electrical Engineering from the University of Washington.
• MBA in Marketing from UW Foster School of Business.

• Known as the Image Sculptor for his transformative work with brand development.
• 25+ years of experience in the industry, Shawn has worked with a diverse clientele, including entrepreneurs, businesses, and brands.
• His portfolio showcases his versatility and ability to bring client’s visions to life through innovative techniques and cutting–edge technology.

• Assistant Professor of Molecular & Human Genetics at Baylor College of Medicine.
• Focuses on the relationship between genomic variation and clinical (phenotypic) expression
  and how this can be leveraged to develop individualized treatment approaches.
• Leads Baylor College of Medicine Genomic Research to Elucidate the Genetics of Rare (BCM–GREGoR) research program

• An American biochemist also is the Isaac Norris Professor of  Biochemistry and Biophysics at the University of Pennsylvania School of Medicine,
• Investigator of the Howard Hughes Medical Institute, who was elected to the National
  Academy of Sciences in 2012.
• Received his Ph.D. in biological chemistry in 1978 from Harvard University and is a fellow of the American Academy of Arts and Sciences.

• Pediatric genetic counselor and instructor at Baylor College of Medicine.
• Provides clinical care, research, and education in the field of genetic counseling.
• Board-certified genetic counselor with a Master of Medical Science degree in human genetics and genetic counseling, and a Master of Science degree in biological sciences.

• Associate Professor of Neurology at Brigham and Women’s Hospital and Harvard Medical School.
• Clinical interests include neurohospitalist medicine, stroke, neuropathic itch, neurological manifestations of systemic diseases, diagnostic decision–making, and the history of neurology.
• Passionate about the impact of social networks on human disease asje combines expertise in clinical neurology and social sciences for this pursuit.

• Founder and CEO of Catalia Health, a company delivering patient engagement across a variety of chronic conditions. The technology and programs are based on Dr. Kidd‘s Ph.D. dissertation at MIT Media Lab.
• Dr. Kidd‘s experience lies in healthcare applications of new technologies, with expertise in artificial intelligence, developing simple interfaces to complex systems, and the application of healthcare technologies to everyday life.

• An attorney with healthcare industry experience, with time at HHS Office of General Counsel CMS division and FDA Office of Policy.
• A veteran of data privacy, data security, and healthcare regulatory issues.
• Served as chapter chair of the Harvard alumni group focused on innovation, and leadership, and as an advisor to a VC fund focused on high–tech and life sciences.